|
1
|
Gore SM, Crombie AK, Batstone MD and Clark
JR: Concurrent chemoradiotherapy compared with surgery and adjuvant
radiotherapy for oral cavity squamous cell carcinoma. Head Neck.
37:518–523. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Crombie AK, Farah C, Tripcony L, Dickie G
and Batstone MD: Primary chemoradiotherapy for oral cavity squamous
cell carcinoma. Oral Oncol. 48:1014–1018. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Lin CY, Wang HM, Kang CJ, Lee LY, Huang
SF, Fan KH, Chen EY, Chen IH, Liao CT and Chang JT: Primary tumor
site as a predictor of treatment outcome for definitive
radiotherapy of advanced-stage oral cavity cancers. Int J Radiat
Oncol Biol Phys. 78:1011–1019. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Nomura T, Murakami R, Toya R, Teshima K,
Nakahara A, Hirai T, Hiraki A, Nakayama H, Yoshitake Y, Ota K, et
al: Phase II study of preoperative concurrent chemoradiation
therapy with S-1 in patients with T4 oral squamous cell carcinoma.
Int J Radiat Oncol Biol Phys. 76:1347–1352. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Harada H, Omura K, Tomioka H, Nakayama H,
Hiraki A, Shinohara M, Yoshihama Y and Shintani S: Multicenter
phase II trial of preoperative chemoradiotherapy with S-1 for
locally advanced oral squamous cell carcinoma. Cancer Chemother
Pharmacol. 71:1059–1064. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Yoshizawa K, Nozaki S, Yoshida K,
Kawashiri S, Kato K, Nakagawa K and Yamamoto E: Two elderly
patients with advanced maxillary gingival carcinoma with complete
response to concurrent radiotherapy and S-1 chemotherapy. Asian J
Oral Maxillofacial Surg. 22:94–98. 2010. View Article : Google Scholar
|
|
7
|
Pignon JP, le Maître A, Maillard E and
Bourhis J; MACH-NC Collaborative Group, : Meta-analysis of
chemotherapy in head and neck cancer (MACH-NC): An update on 93
randomised trials and 17,346 patients. Radiother Oncol. 92:4–14.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Harada K, Kawaguchi S, Onoue T Supriatno,
Yoshida H and Sato M: Combined effects of the oral fluoropyrimidine
anticancer agent, S-1 and radiation on human oral cancer cells.
Oral Oncol. 40:713–719. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Nakagawa T, Otsuki N, Masai Y, Sasaki R,
Tsukuda M and Nibu K: Additive effects of oral fluoropyrimidine
derivative S-1 and radiation on human hypopharyngeal cancer
xenografts. Acta Otolaryngol. 128:936–940. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Gregoire V, Levendag P, Ang KK, Bernier J,
Braaksma M, Budach V, Chao C, Coche E, Cooper JS, Cosnard G, et al:
CT-based delineation of lymph node levels and related CTVs in the
node-negative neck: DAHANCA, EORTC, GORTEC, NCIC, RTOG consensus
guidelines. Radiother Oncol. 69:227–236. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Vorwerk H and Hess CF: Guidelines for
delineation of lymphatic clinical target volumes for high conformal
radiotherapy: Head and neck region. Radiat Oncol. 6:972011.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Gregoire V, Ang K, Budach W, Grau C,
Hamoir M, Langendijk JA, Lee A, Le QT, Maingon P, Nutting C, et al:
Delineation of the neck node levels for head and neck tumors: A
2013 update. DAHANCA, EORTC, HKNPCSG, NCIC CTG NCRI, RTOG, TROG
consensus guidelines. Radiother Oncol. 110:172–181. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Xing Y, Zhang J, Lin H, Gold KA, Sturgis
EM, Garden AS, Lee JJ and William WN Jr.: Relation between the
level of lymph node metastasis and survival in locally advanced
head and neck squamous cell carcinoma. Cancer. 122:534–545. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Murakami R, Nakayama H, Semba A, Hiraki A,
Nagata M, Kawahara K, Shiraishi S, Hirai T, Uozumi H and Yamashita
Y: Prognostic impact of the level of nodal involvement:
Retrospective analysis of patients with advanced oral squamous cell
carcinoma. Br J Oral Maxillofac Surg. 55:50–55. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Ng SH, Yen TC, Liao CT, Chang JT, Chan SC,
Ko SF, Wang HM and Wong HF: 18F-FDG PET and CT/MRI in oral cavity
squamous cell carcinoma: A prospective study of 124 patients with
histologic correlation. J Nucl Med. 46:1136–1143. 2005.PubMed/NCBI
|
|
16
|
Murakami R, Uozumi H, Hirai T, Nishimura
R, Shiraishi S, Ota K, Murakami D, Tomiguchi S, Oya N, Katsuragawa
S and Yamashita Y: Impact of FDG-PET/CT imaging on nodal staging
for head-and-neck squamous cell carcinoma. Int J Radiat Oncol Biol
Phys. 68:377–382. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Amit M, Yen TC, Liao CT, Chaturvedi P,
Agarwal JP, Kowalski LP, Ebrahimi A, Clark JR, Kreppel M, Zöller J,
et al: Improvement in survival of patients with oral cavity
squamous cell carcinoma: An international collaborative study.
Cancer. 119:4242–4248. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Kreppel M, Drebber U, Rothamel D, Eich HT,
Kubler A, Scheer M and Zöller JE: Prognostic impact of different
TNM-based stage groupings for oral squamous cell carcinoma. Head
Neck. 33:1467–1475. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Kessler P, Grabenbauer G, Leher A,
Bloch-Birkholz A, Vairaktaris E and Neukam FW: Neoadjuvant and
adjuvant therapy in patients with oral squamous cell carcinoma
Long-term survival in a prospective, non-randomized study. Br J
Oral Maxillofac Surg. 46:1–5. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Browman GP, Hodson DI, Mackenzie RJ,
Bestic N and Zuraw L; Cancer Care Ontario Practice Guideline
Initiative Head and Neck Cancer Disease Site Group, : Choosing a
concomitant chemotherapy and radiotherapy regimen for squamous cell
head and neck cancer: A systematic review of the published
literature with subgroup analysis. Head Neck. 23:579–589. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Adelstein DJ, Li Y, Adams GL, Wagner H Jr,
Kish JA, Ensley JF, Schuller DE and Forastiere AA: An intergroup
phase III comparison of standard radiation therapy and two
schedules of concurrent chemoradiotherapy in patients with
unresectable squamous cell head and neck cancer. J Clin Oncol.
21:92–98. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Jones AS, Roland NJ, Field JK and Phillips
DE: The level of cervical lymph node metastases: Their prognostic
relevance and relationship with head and neck squamous carcinoma
primary sites. Clin Otolaryngol Allied Sci. 19:63–69. 1994.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Woolgar JA: The topography of cervical
lymph node metastases revisited: The histological findings in 526
sides of neck dissection from 439 previously untreated patients.
Int J Oral Maxillofac Surg. 36:219–225. 2007. View Article : Google Scholar : PubMed/NCBI
|
